These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6203643)

  • 21. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Growing teratoma syndrome in metastatic germinal non-seminomatous testicular tumors].
    Alcaraz A; Arango O; Talbot-Wrigth R; Gelabert A; Ayuso C; Alvarez-Vijande R; Bielsa O; Vesa J; Carretero P
    Actas Urol Esp; 1990; 14(3):239-42. PubMed ID: 2239407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
    Stoter G; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M; Sylvester R
    J Clin Oncol; 1986 Aug; 4(8):1199-206. PubMed ID: 2426419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late recurrence of mature teratoma in nonseminomatous testicular tumors after PVB chemotherapy and surgery.
    Gelderman WA; Scraffordt Koops H; Sleijfer DT; Oosterhuis JW; Oldhoff J
    Urology; 1989 Jan; 33(1):10-4. PubMed ID: 2463704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Caval involvement in advanced-stage non-seminoma testicular tumors: surgical strategy and long-term results].
    Tavolini IM; Norcen M; Oliva G; Nigro F; Benedetto G; Mazzariol C; Bassi P
    Arch Ital Urol Androl; 2002 Jun; 74(2):69-76. PubMed ID: 12161940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seminoma with elevated human chorionic gonadotropin. The case for retroperitoneal lymph node dissection.
    Pritchett TR; Skinner DG; Selser SF; Kern WH
    Urology; 1985 Apr; 25(4):344-6. PubMed ID: 2580384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postchemotherapy surgery in nonseminomatous testicular tumors.
    Hornák M; Ondrus D; Matoska J; Cársky S
    Eur Urol; 1996; 29(3):325-30. PubMed ID: 8740018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
    Djaladat H; Nichols C; Daneshmand S
    Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
    Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R
    Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
    Wolf DJ; Williams JJ
    Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
    [No Abstract]   [Full Text] [Related]  

  • 31. Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy.
    Reddel RR; Thompson JF; Raghavan D; Tattersall MH; Levi JA; Coupland GA; Fox RM; Coates AS; Woods RL; Ng AB
    J Surg Oncol; 1983 Aug; 23(4):223-7. PubMed ID: 6192289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
    Coogan CL; Foster RS; Rowland RG; Bihrle R; Smith ER; Einhorn LH; Roth BJ; Donohue JP
    Urology; 1997 Dec; 50(6):957-62. PubMed ID: 9426730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
    de Bono JS; Paul J; Simpson A; Anthoney A; Kirk D; Underwood M; Graham J; Kaye SB
    Br J Cancer; 2000 Aug; 83(4):426-30. PubMed ID: 10945485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
    Skinner DG; Scardino PT
    Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
    [No Abstract]   [Full Text] [Related]  

  • 37. Current concepts in the management of testicular germ cell tumours in adults. A review.
    Ekman P
    Int J Androl; 1982 Aug; 5(4):356-66. PubMed ID: 6183226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and therapy of malignant testicular neoplasms].
    Douwes FR; Yu D; Truss F
    Onkologie; 1978 Oct; 1(5):185-92. PubMed ID: 83558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case report of infantile testicular cancer: dissection of paraaortic lymph node involvement indicated by gradual rise in serum alpha-fetoprotein after orchiectomy].
    Takeuchi T; Kuriyama M; Saito A; Chang PK; Kanematsu M; Ban Y; Nishiura T; Tanaka T
    Hinyokika Kiyo; 1985 Sep; 31(9):1643-8. PubMed ID: 2417467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
    Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
    Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.